November 2019

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.

Diagnoses have increased with disease awareness, highlighting a great need for markers to help influence treatment decisions.

A growing emphasis on access to care and ease of use drives a digital revolution in the treatment of mental comorbidities in multiple sclerosis.

The assistant professor of clinical neurology at Keck School of Medicine University of Southern California in Los Angeles sat down with NeurologyLive for a Q&A discussing using steroids as treatment for multiple sclerosis.


September 29, 2020

The benefits of a multidisciplinary hub for disease management can mitigate the costs.

Although there are no cures for MS at present, the treatment landscape has changed significantly, with over a dozen approved disease-modifying therapies (DMTs) representing multiple classes of agents with different mechanisms of action.